Dr. Douglas Golenbock
Douglas Golenbock is Chief of the Division of Infectious Diseases and Immunology in the Department of Medicine at the University of Massachusetts. He holds a joint appointment in the Department of Microbiology and Physiological Systems. The goal of his laboratory is to characterize phagocytic receptors that recognize the presence of microbes in the context of infectious illnesses. As the mechanisms of inflammation in infectious diseases are similar to those associated with sterile inflammation, his group also studies Alzheimer's Disease. Dr. Golenbock has made several pioneering contributions to the field of innate immunity, specifically in the field of Toll-like receptors in infection and inflammation. Most recently, he has focused on neuroinflammation in Alzheimer’s Disease, identifying with colleagues in Bonn the NLRP3 inflammasome as an important component of neuronal injury due to beta amyloid. Dr. Golenbock has been elected as a member of the American Society for Clinical Investigation, the American Association of Physicians, the Brazilian Academy of Sciences (for his work in malaria there) and most recently received the first Pillar Chair in Biomedical Research.
product development , biotechnology , Business management